APA

Bart S., Cannon K., Herrington D., Mills R., Forleo-Neto E., Lindert K. & Abdul Mateen A. (20171023). Immunogenicity and safety of a cell culture-based quadrivalent influenza vaccine in adults: A Phase III, double-blind, multicenter, randomized, non-inferiority study. : Human vaccines & immunotherapeutics.

Chicago

Bart Stephan, Cannon Kevin, Herrington Darrell, Mills Richard, Forleo-Neto Eduardo, Lindert Kelly and Abdul Mateen Ahmed. 20171023. Immunogenicity and safety of a cell culture-based quadrivalent influenza vaccine in adults: A Phase III, double-blind, multicenter, randomized, non-inferiority study. : Human vaccines & immunotherapeutics.

Harvard

Bart S., Cannon K., Herrington D., Mills R., Forleo-Neto E., Lindert K. and Abdul Mateen A. (20171023). Immunogenicity and safety of a cell culture-based quadrivalent influenza vaccine in adults: A Phase III, double-blind, multicenter, randomized, non-inferiority study. : Human vaccines & immunotherapeutics.

MLA

Bart Stephan, Cannon Kevin, Herrington Darrell, Mills Richard, Forleo-Neto Eduardo, Lindert Kelly and Abdul Mateen Ahmed. Immunogenicity and safety of a cell culture-based quadrivalent influenza vaccine in adults: A Phase III, double-blind, multicenter, randomized, non-inferiority study. : Human vaccines & immunotherapeutics. 20171023.